CLINICAL TRIALS PROFILE FOR LINCOCIN

All Clinical Trials for LINCOCIN

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01876628 ↗	Adjunctive Clindamycin for Cellulitis: C4C Trial.	Unknown status	Public Health England	Phase 4	2013-10-01	The aim of this study is to see whether the addition of Clindamycin, a protein inhibiting antibiotic, to the standard antibiotic treatment of limb cellulitis, with Flucloxacillin, results in less tissue damage and a more rapid resolution of both systemic and local features, in a cost-effective manner. This study is a randomised controlled trial comparing Clindamycin with placebo.
NCT01876628 ↗	Adjunctive Clindamycin for Cellulitis: C4C Trial.	Unknown status	University of Bristol	Phase 4	2013-10-01	The aim of this study is to see whether the addition of Clindamycin, a protein inhibiting antibiotic, to the standard antibiotic treatment of limb cellulitis, with Flucloxacillin, results in less tissue damage and a more rapid resolution of both systemic and local features, in a cost-effective manner. This study is a randomised controlled trial comparing Clindamycin with placebo.
NCT01876628 ↗	Adjunctive Clindamycin for Cellulitis: C4C Trial.	Unknown status	University Hospitals Bristol and Weston NHS Foundation Trust	Phase 4	2013-10-01	The aim of this study is to see whether the addition of Clindamycin, a protein inhibiting antibiotic, to the standard antibiotic treatment of limb cellulitis, with Flucloxacillin, results in less tissue damage and a more rapid resolution of both systemic and local features, in a cost-effective manner. This study is a randomised controlled trial comparing Clindamycin with placebo.
NCT01876628 ↗	Adjunctive Clindamycin for Cellulitis: C4C Trial.	Unknown status	University Hospitals Bristol NHS Foundation Trust	Phase 4	2013-10-01	The aim of this study is to see whether the addition of Clindamycin, a protein inhibiting antibiotic, to the standard antibiotic treatment of limb cellulitis, with Flucloxacillin, results in less tissue damage and a more rapid resolution of both systemic and local features, in a cost-effective manner. This study is a randomised controlled trial comparing Clindamycin with placebo.

Clinical Trial Conditions for LINCOCIN

Condition Name

Condition Name for LINCOCIN
Intervention	Trials
Cellulitis	1

Condition MeSH

Condition MeSH for LINCOCIN
Intervention	Trials
Cellulitis	1

Clinical Trial Locations for LINCOCIN

Trials by Country

Trials by Country for LINCOCIN
Location	Trials
United Kingdom	1

Clinical Trial Progress for LINCOCIN

Clinical Trial Phase

Clinical Trial Phase for LINCOCIN
Clinical Trial Phase	Trials
Phase 4	1

Clinical Trial Status

Clinical Trial Status for LINCOCIN
Clinical Trial Phase	Trials
Unknown status	1

Clinical Trial Sponsors for LINCOCIN

Sponsor Name

Sponsor Name for LINCOCIN
Sponsor	Trials
Public Health England	1
University of Bristol	1
University Hospitals Bristol and Weston NHS Foundation Trust	1

Sponsor Type

Sponsor Type for LINCOCIN
Sponsor	Trials
Other	4